Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE continuous infusion versus bolus infusion in hemophilia A during major orthopedic surgery
2005-005697-71Phase 3Completed
- Sponsor
- Baxalta
- Start
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Baxalta. Started Dec 2005; status: completed.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2005-005697-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005697-71.